Shalby 

₹152.71
11
+₹0.78+0.51% Friday 10:00

Statistics

Day High
153.3
Day Low
152.6
52W High
274.7
52W Low
125.82
Volume
94
Avg. Volume
-
Mkt Cap
16.42B
P/E Ratio
52.87
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Oct 24
₹1.20
Aug 23
₹1.20
Sep 22
₹1.00
Oct 21
₹1.00
Sep 20
₹0.50
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

20OctExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

3.17%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
17.23BRevenue
546.93MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SHALBY.NSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Shalby Limited operates a chain of multi-specialty hospitals in India and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers rheumatology, knee and hip joint replacement, spine surgery, orthopedic and trauma, arthroscopy, and arthroplasty; cardiothoracic and vascular surgery, coronary angiography, angioplasty and stenting, and cardiology services; root canal treatment, dental implants, crowns bridges, dentures, orthodontic treatment, dental cosmetic, teeth whitening, pediatric dentistry, dental veneers, gum treatment, and laser dentistry; dermatology; emergency and general medicine; cochlear implants and balloon sinuplasty; gastroenterology, obesity surgery, and endoscopy and laparoscopy; intensive and critical care; nephrology, urology, kidney transplant, dialysis, and interventional nephrology; and general surgery comprising varicose, hernia, and piles surgery. The company also provides liver transplant; maxillofacial surgery; neurology, ideal stroke treatment, epilepsy, endovascular/interventional neurosurgery, and trans cranial doppler; obstetrics and gynaecology; surgical oncology, medical oncology, radiation oncology, bone marrow transplant, onco-psychology, onco-dietetics, onco-physiotherapy, and home care; ophthalmology; paediatrics; pathology and microbiology; psychiatry; pulmonology and chest; and interventional and diagnostic radiology. The company was formerly known as Shalby Hospitals Limited and changed its name to Shalby Limited in February 2008. Shalby Limited was founded in 1994 and is based in Ahmedabad, India.
Show more...
CEO
Vikram Indrajit Shah
Employees
2592
Country
India
ISIN
INE597J01018

Listings

0 Comments

Share your thoughts

FAQ

What is Shalby stock price today?
The current price of SHALBY.NSE is ₹152.71 INR — it has increased by +0.51% in the past 24 hours. Watch Shalby stock price performance more closely on the chart.
What is Shalby stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on NSE (India) exchange Shalby stocks are traded under the ticker SHALBY.NSE.
Is Shalby stock price growing?
SHALBY.NSE stock has fallen by -1.22% compared to the previous week, the month change is a -5.89% fall, over the last year Shalby has showed a -30.41% decrease.
What is Shalby market cap?
Today Shalby has the market capitalization of 16.42B
When is the next Shalby earnings date?
Shalby is going to release the next earnings report on October 20, 2026.
What is Shalby revenue for the last year?
Shalby revenue for the last year amounts to 17.23B INR.
What is Shalby net income for the last year?
SHALBY.NSE net income for the last year is 546.93M INR.
Does Shalby pay dividends?
Yes, SHALBY.NSE dividends are paid annual. The last dividend per share was 1.2 INR. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Shalby have?
As of September 05, 2026, the company has 2,592 employees.
In which sector is Shalby located?
Shalby operates in the Health & Wellness sector.
When did Shalby complete a stock split?
Shalby has not had any recent stock splits.
Where is Shalby headquartered?
Shalby is headquartered in Ahmedabad, India.